{"id":"W4415942115","doi":"10.1016/j.annonc.2025.08.2705","title":"2084eTiP A phase III study of ateganosine (THIO; 6-thio-2'-deoxyguanosine) sequenced with immune checkpoint inhibitor (ICI) versus standard of care chemotherapy in ICI-resistant advanced NSCLC: THIO-104 trial in progress","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Institute of Cancer Research; National Cancer Institute; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Università degli Studi di Perugia; Istituto Oncologico Veneto; Sapienza Università di Roma; Università degli Studi di Padova","keywords":"Standard of care; Chemotherapy; Chemotherapy regimen; Immunotherapy; Immune checkpoint; Clinical trial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001319262,0.001514471,0.002241035,0.0005303705,0.0004468505,0.001434311,0.001285523,0.001782998,0.008497809],"category_scores_gemma":[0.0008369496,0.000553736,0.00206188,0.0004498514,0.0009223607,0.0008601857,0.0004271631,0.004854316,0.001972823],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001086743,"about_ca_system_score_gemma":0.001807188,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002092607,"about_ca_topic_score_gemma":0.005669628,"domain_scores_codex":[0.99972,0.0001304154,0.000009885397,0.00004118735,0.00002197631,0.00007653036],"domain_scores_gemma":[0.9994705,0.00009764322,0.00006566104,0.00004218263,0.00003755438,0.0002864818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7650545,0.02536361,0.004145304,0.001407505,0.002913261,0.0003087116,0.0002157652,0.004135409,0.02705182,0.001297623,0.01571961,0.1523868],"study_design_scores_gemma":[0.746169,0.2359662,0.006243063,0.0000852423,0.0008298485,0.00027485,0.00007282807,0.001291283,0.002338751,0.0004819354,0.006210512,0.00003640589],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9715391,0.006450368,0.00111578,0.002571114,0.0008119559,0.002921857,0.005149096,0.0004778654,0.00896284],"genre_scores_gemma":[0.949259,0.00695204,0.003888894,0.003897765,0.0006139555,0.004156963,0.01143786,0.0001632477,0.0196301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008497809,"threshold_uncertainty_score":0.02842796,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05889386829468098,"score_gpt":0.4324994319029268,"score_spread":0.3736055636082458,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}